Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity

Wei Lin,Zhiguang Zhao,Wenjun Du,Zhonglin Ni,Chenwei Pan,Peipei Fang,Jie Li,Lu ZhuGe,Shuanghong Jin
DOI: https://doi.org/10.1007/s10620-023-08175-x
2024-01-05
Digestive Diseases and Sciences
Abstract:Previous reports have suggested IFI16 as a tumor suppressor in hepatocellular carcinoma (HC). Nonetheless, the biological significance of IFI16 and its mechanism concerning resistance to cisplatin (DDP) in HC requires further exploration.
gastroenterology & hepatology
What problem does this paper attempt to address?